Sunshine Biopharma Inc. (SBFM) Operating margin 2019–2025
Sunshine Biopharma Inc. (SBFM) operating margin by fiscal year — reported operating income divided by reported revenue.
-17.2%FY2025 · since FY2019: -3037.9% → -17.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -17.2% | -0.5 pp |
| FY2024 | -16.7% | +3.2 pp |
| FY2023 | -19.9% | +601.5 pp |
| FY2022 | -621.3% | +446.9 pp |
| FY2021 | -1068.2% | -260.4 pp |
| FY2020 | -807.8% | +2230.1 pp |
| FY2019 | -3037.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFM financial trends
SBFM RevenueSBFM Net incomeSBFM Net marginSBFM Gross profitSBFM Gross marginSBFM Operating incomeSBFM Operating cash flowSBFM Free cash flowSBFM Capital expendituresSBFM Return on equitySBFM Stock buybacksSBFM Dividends paidSBFM Total assetsSBFM Total liabilitiesSBFM Shareholders’ equitySBFM overview →